Unknown

Dataset Information

0

Opioid-induced constipation in patients with cancer pain in Japan (OIC-J study): a post hoc subgroup analysis of patients with lung cancer.


ABSTRACT:

Objective

To evaluate the opioid-induced constipation burden in the subgroup of patients with lung cancer who participated in the observational Opioid-Induced Constipation in Patients with Cancer Pain in Japan (OIC-J) study.

Methods

The prospective, observational study, OIC-J, included 212 patients with various tumour types, 33% of whom had lung cancer. The incidence of opioid-induced constipation was evaluated using several diagnostic criteria, as well as the physician's diagnosis and patient's subjective assessment. Following initiation of opioids, patients recorded details of bowel movements (i.e. date/time, Bristol Stool Scale form, sensations of incomplete evacuation or anorectal obstruction/blockage and degree of straining) in a diary for 2 weeks. Relationships between patient characteristics and opioid-induced constipation onset and effects of opioid-induced constipation on quality of life were explored.

Results

In total, 69 patients were included in this post hoc analysis. The incidence of opioid-induced constipation varied (39.1-59.1%) depending on which diagnostic criteria was used. Diagnostic criteria that included a quality component or a patient's feeling of bowel movement as an evaluation item (i.e. Rome IV, physician's diagnosis, Bowel Function Index, patient's assessment) showed higher incidences of opioid-induced constipation than recording the number of spontaneous bowel movements alone. Opioid-induced constipation occurred rapidly after initiating opioids and had a significant impact on Patient Assessment of Constipation Symptoms total score (P = 0.0031). Patient baseline characteristics did not appear to be predictive of opioid-induced constipation onset.

Conclusions

In patients with lung cancer, opioid-induced constipation can occur quickly after initiating opioids and can negatively impact quality of life. Early management of opioid-induced constipation, with a focus on quality-of-life improvement and patient's assessments of bowel movements, is important for these patients.

SUBMITTER: Imai H 

PROVIDER: S-EPMC7937418 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Opioid-induced constipation in patients with cancer pain in Japan (OIC-J study): a post hoc subgroup analysis of patients with lung cancer.

Imai Hisao H   Fumita Soichi S   Harada Toshiyuki T   Noriyuki Toshio T   Gamoh Makio M   Okamoto Masaharu M   Akashi Yusaku Y   Kizawa Yoshiyuki Y   Tokoro Akihiro A  

Japanese journal of clinical oncology 20210301 3


<h4>Objective</h4>To evaluate the opioid-induced constipation burden in the subgroup of patients with lung cancer who participated in the observational Opioid-Induced Constipation in Patients with Cancer Pain in Japan (OIC-J) study.<h4>Methods</h4>The prospective, observational study, OIC-J, included 212 patients with various tumour types, 33% of whom had lung cancer. The incidence of opioid-induced constipation was evaluated using several diagnostic criteria, as well as the physician's diagnosi  ...[more]

Similar Datasets

| S-EPMC7788034 | biostudies-literature
| S-EPMC8472365 | biostudies-literature
| S-EPMC9314494 | biostudies-literature
| S-EPMC4896913 | biostudies-literature
| S-EPMC8485099 | biostudies-literature
| S-EPMC7096364 | biostudies-literature
| S-EPMC4536845 | biostudies-literature
| S-EPMC6307492 | biostudies-literature
| S-EPMC9939183 | biostudies-literature
| S-EPMC4282321 | biostudies-literature